We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Analyzing immune responses to varied mRNA and protein vaccine sequences

    In response to the COVID-19 pandemic, different types of vaccines, such as inactive, live-attenuated, messenger RNA (mRNA), and protein subunit, have...

    Hyeong-Jun Park, Yoo-** Bang, ... Jae-Hwan Nam in npj Vaccines
    Article Open access 05 June 2023
  2. Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models

    Respiratory syncytial virus (RSV) is a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously...

    Eirikur Saeland, Leslie van der Fits, ... Roland C. Zahn in npj Vaccines
    Article Open access 23 March 2023
  3. Prophylactic Hepatitis E Vaccine

    The hepatitis E has been increasingly recognized as an underestimated global disease burden in recent years. Subpopulations with more serious...
    Jun Zhang, Zizheng Zheng, Ningshao **a in Hepatitis E Virus
    Chapter 2023
  4. Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

    During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such...

    M. B. Borgoyakova, L. I. Karpenko, ... A. A. Ilyichev in Bulletin of Experimental Biology and Medicine
    Article 01 December 2022
  5. Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein

    A recombinant, replication-defective, adenovirus-vectored vaccine expressing the H surface glycoprotein of peste des petits ruminants virus (PPRV)...

    Karin E. Darpel, Amanda Corla, ... Carrie Batten in npj Vaccines
    Article Open access 03 June 2024
  6. Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents

    Respiratory syncytial virus (RSV) is a leading cause of upper and lower respiratory tract infection, especially in children and the elderly. Various...

    Shingo Umemoto, Rika Nakahashi-Ouchida, ... Hiroshi Kiyono in npj Vaccines
    Article Open access 24 July 2023
  7. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

    In response to COVID-19 pandemic, we have launched a vaccine development program against SARS-CoV-2. Here we report the safety, tolerability, and...

    Lorna Leal, Judit Pich, ... Elia Torroella in npj Vaccines
    Article Open access 29 September 2023
  8. Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate

    Diarrhea caused by Shigella has been associated with high morbidity and mortality in young children worldwide. There are no licensed vaccines, and...

    Girmay Desalegn, Chitradevi S. Tamilselvi, ... Marcela F. Pasetti in npj Vaccines
    Article Open access 02 January 2024
  9. Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats

    ZF2001, a protein subunit vaccine against coronavirus disease 2019 (COVID-19), contains recombinant tandem repeat of dimeric receptor-binding domain...

    Yisheng Song, **** Shao, ... Lijiang Zhang in npj Vaccines
    Article Open access 24 May 2023
  10. Introduction of protein vaccine candidate based on AP65, AP33, and α-actinin proteins against Trichomonas vaginalis parasite: an immunoinformatics design

    Background

    Trichomonas vaginalis is the most common nonviral sexually transmitted disease (STI) worldwide. Vaccination is generally considered to be...

    Forozan Ghasemi Nezhad, Afsaneh Karmostaji, ... Khadijeh Ahmadi in Parasites & Vectors
    Article Open access 31 March 2024
  11. Vaccine Development Against Melioidosis

    Melioidosis in an infectious disease of humans and animals caused by the bacterium Burkholderia pseudomallei. Melioidosis is often considered a...
    Chapter Open access 2023
  12. Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein

    Background

    Human T-lymphotropic virus 1 (HTLV-1) is associated with the development of several pathologies and chronic infection in humans. The...

    D. S. O. Daian e Silva, L. J. Cox, ... E. F. Barbosa-Stancioli in Virology Journal
    Article Open access 19 December 2023
  13. Current Status of Vaccine Development for Monkeypox Virus

    Monkeypox virusMonkeypox virus (MPXV) of poxviridae family causes a zoonotic disease called monkeypox (Mpox). MPXV cases have a fatality ratio...
    Amber Rastogi, Manoj Kumar in Poxviruses
    Chapter 2024
  14. Immune response induced by recombinant pres2/S-protein and a pres2-S-protein fused with a core 18-27 antigen fragment of hepatitis B virus compared to conventional HBV vaccine

    Although comprehensive vaccination is the cornerstone of public health programs to control hepatitis B virus (HBV) infections, 5% of people who...

    Elaheh Gholami Parizad, Abbas Ali Imani Fooladi, ... Afra Khosravi in Virus Genes
    Article 04 May 2023
  15. Vaccine Development for Human Leishmaniasis

    The development of vaccines for human leishmaniasis is one of the most important approaches for effectively controlling and/or eradicating the...
    Marianna de Carvalho ClĂ­maco, Lucas Kraemer, Ricardo Toshio Fujiwara in Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
    Chapter Open access 2023
  16. C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4

    The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a multifunctional protein with receptor recognition ability that...

    **angfei Ren, Zhe Zeng, ... Guoyuan Wen in Archives of Virology
    Article 07 July 2023
  17. Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection

    The bacteria Vibrio cholerae causes cholera, an acute diarrheal infection that can lead to dehydration and even death. Over 100,000 people die each...

    Elijah Kolawole Oladipo, Olawumi Elizabeth Akindiya, ... Musa Oladayo Babalola in Immunogenetics
    Article 02 December 2022
  18. Relevance for mRNA Vaccine Safety

    This chapter describes how the above unsubstantiated assumptions underlying mRNA vaccines may impact vaccine safety. Again, the analysis here is done...
    Chapter 2023
  19. In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A

    Background

    The pathogenicity of pneumococcus with high morbidity, mortality, and multi-drug resistance patterns has been increasing. The limited...

    Elnaz Afshari, Reza Ahangari Cohan, ... Seyed Fazlollah Mousavi in Journal of Translational Medicine
    Article Open access 10 January 2023
  20. Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction–based approaches

    Acinetobacter baumannii is one of the major pathogenic ESKAPE bacterium, which is responsible for about more than 722,000 cases in a year, globally....

    Jyotirmayee Dey, Soumya Ranjan Mahapatra, ... Mrutyunjay Suar in Immunologic Research
    Article 06 April 2023
Did you find what you were looking for? Share feedback.